JNJ monthly performance report
View JNJ's monthly returns, drawdown, and seasonality trends — updated every month.
JNJ monthly report
—
Key takeaways
- Johnson & Johnson (JNJ) closed November 2026 at $285.75, up 4.59% for the month and +46.35% over the trailing 12 months.
- Year-to-date, JNJ is +38.08%, outperforming the S&P 500 which has returned +10.62% YTD.
- The stock is trading +14.40% versus its 200-day moving average ($249.77), a bullish technical signal.
- Over the past three years, JNJ has outperformed the S&P 500 by +22.18%, with a relative strength index reading of 112.9.
- Win rate over the trailing 39 months stands at 59% — 23 positive months versus 16 negative months.
Johnson & Johnson ended November 2026 at $285.75, posting a monthly return of +4.59%. The S&P 500 returned −0.18% over the same window, leaving relative performance at +4.77%.
The current quarter stands at +7.94% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +14.40% versus the 200-day moving average ($249.77).
Year-to-date, JNJ is +38.08% against SPY +10.62%, a gap of +27.45%. The stock is currently −0.82% below its 52-week high, with maximum 3-year drawdown at −15.13%.
| Period | JNJ | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +0.79% | −0.36% | +1.15% |
| 1 Week | +3.45% | +2.59% | +0.86% |
| 1 Month | +4.59% | −0.18% | +4.77% |
| 3 Months | +8.91% | −2.37% | +11.28% |
| 6 Months | +23.81% | +0.83% | +22.98% |
| YTD | +38.08% | +10.62% | +27.45% |
| 12 Months | +46.35% | +12.25% | +34.10% |
| 3 Years | +93.56% | +71.37% | +22.18% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jun 2026 | +12.71% |
| #2 | Jan 2026 | +9.81% |
| #3 | Nov 2025 | +9.56% |
| #4 | Feb 2026 | +9.32% |
| #5 | Feb 2025 | +8.46% |
| Rank | Month | Return |
|---|---|---|
| #1 | Apr 2024 | −8.60% |
| #2 | Dec 2024 | −6.70% |
| #3 | Apr 2026 | −5.97% |
| #4 | Apr 2025 | −5.75% |
| #5 | Oct 2023 | −4.76% |
| Quarter | Return |
|---|---|
| Q3 2025 | +21.39% |
| Q4 2025 | +11.61% |
| Q1 2026 | +18.12% |
| Q2 2026 | +3.90% |
| Q3 2026 | +4.24% |
| Q4 2026 (QTD) | +7.94% |
| Year | Return |
|---|---|
| 2023 | −11.27% |
| 2024 | −7.73% |
| 2025 | +43.10% |
| 2026 | +38.08% |
| Metric | Value |
|---|---|
| 52-Week High | $288.11 (2026-11-13) |
| 52-Week Low | $193.07 (2025-11-12) |
| Current Price | $285.75 |
| 200-Day Moving Average | $249.77 |
| Price vs 200DMA | +14.40% |
| 3-Year Maximum Drawdown | −15.13% (2025-01-10) |
| Current Drawdown from 52W High | −0.82% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 112.9 |
| 3-Year Excess Return vs S&P 500 | +22.18% |
| RS Peak | 114.4 (Mar 2026) |
| RS Trough | 70.7 (Dec 2024) |
| Status | Outperforming Benchmark |
Frequently asked questions
What was JNJ's return for this report period?
JNJ returned +4.59% in the latest monthly window ending 2026-11-13.
Has JNJ outperformed SPY year to date?
YTD JNJ: +38.08% vs SPY: +10.62%.
What is JNJ's 12-month return?
+46.35% over the trailing 12 months.
Is JNJ above or below its 200-day moving average?
Price is +14.40% versus 200DMA ($249.77).
What is the maximum drawdown in the 3-year window?
−15.13% on 2025-01-10.